U.S. FDA nod for Aurobindo’s Droxidopa capsules

U.S. FDA nod for Aurobindo’s Droxidopa capsules

The Hindu

Drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (US FDA) to manufacture and market Droxidopa capsules, 100 mg, 200 mg and 300 mg. Droxidopa Capsules are generic version of Lundbeck NA’s Northera capsules and will be launched immediately, the company said on Friday. The approved product has an estimated market size of $352 million for the 12 months ending December 2020, a release said quoting IQVIA numbers.
Read full story on The Hindu
Share this story on:-
More Related News
DGCA clears IndiGo’s plea for exemption from night-duty limits for pilots

DGCA grants IndiGo exemption from night-duty limits for pilots amid widespread flight cancellations and operational disruptions.

RBI to launch two-months campaign to resolve pending grievances with Ombudsman

RBI to launch a two-month campaign in January 2026 to address pending grievances with the Ombudsman for improved customer service.

RBI to conduct ₹1 lakh crore OMO during December to inject liquidity

RBI plans ₹1 lakh crore OMO in December to boost liquidity amid upcoming tax payments, ensuring stability in the banking system.

Why IndiGo has delayed, cancelled hundreds of flights

IndiGo faces ongoing flight delays and cancellations due to technology issues, weather, and new crew rostering rules.

Stock markets witness volatile trends

Stock markets experience volatility as investors await RBI's monetary policy amid foreign fund outflows and mixed global trends.

ED attaches fresh assets worth over ₹1,100 crore in case against Anil Ambani’s Reliance Group

ED attaches assets worth ₹1,120 crore in Anil Ambani's Reliance Group case, totaling ₹10,000 crore amid money laundering probe.

Rupee rises 20 paise to 89.69 against U.S. dollar

Rupee rises 20 paise to 89.69 against the dollar as investors await RBI's monetary policy decision amidst market pressures.

Economic offenders who fled the country owe ₹39,000 crores to Indian Banks?

Just nine Fugitive Economic Offenders (FEOs) owed Indian banks over ₹58,000 crore in principal and interest. To date, banks have recovered just over ₹19,000 crore — roughly 33% of the total dues.

Indian businesses have ample opportunity in Russia if only they take ‘leap of faith’: Goyal

Commerce Minister Piyush Goyal urges Indian businesses to seize opportunities in Russia's market, addressing talent shortages and trade demands.

‘Premiumisation driving growth in beauty, personal care industry’

Premiumisation is driving the growth in beauty and personal care industry in India and this segment is growing faster than the products made for the masses, industry executives said at Cosmoprof India 2025, a beauty & personal care industry event currently underway in Mumbai.

We will burn the planet expanding AI at the current technology, says NTT Data’s Khan

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.

Rupee rises 19 paise to close at 89.96 against U.S. dollar

The Rupee appreciated by 19 paise to close at 89.96 against the U.S. dollar amid weak dollar index support.

India seeks bigger slice of China's expanding tea market at buyer-seller meet

India aims to expand its tea exports to China, highlighting diverse varieties like Darjeeling and Masala at a recent buyer-seller meet.